openPR Logo
Press release

Endometriosis Pain Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, Growth Prospects, and Key Companies

08-29-2022 06:45 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Endometriosis Pain Pipeline

Endometriosis Pain Pipeline

Endometriosis is one of the most common medical conditions affecting the abdomen (lower belly) in women. In endometriosis, the kind of tissue that normally lines the inside of the womb (endometrial tissue) also grows outside of it. The medical term for endometrial tissue that has grown outside of the womb is "endometrial implants.

"Endometriosis Pain Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Endometriosis Pain Market.
The Endometriosis Pain Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers, acquisition, funding, designations, and other product-related details.

To know more about the Endometriosis pain pipeline report, know more here: https://www.delveinsight.com/sample-request/endometriosis-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

DelveInsight's Endometriosis Pain Pipeline Report covers around 5+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Endometriosis Pain Emerging Drugs Under Different Phases of Clinical Development Include:
• Quinagolide: Ferring Pharmaceuticals
• Linzagolix: ObsEva
And Others

Further product details are provided in the report. Download the report to learn more about the emerging therapies at: https://www.delveinsight.com/sample-request/endometriosis-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Endometriosis Pipeline Analysis
The report provides insights into:
• The report provides detailed insights about companies that are developing therapies for the treatment of Endometriosis Pain with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for the Endometriosis Pain Treatment.
• Endometriosis Pain key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Endometriosis Pain Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Endometriosis Pain market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Request for Sample PDF Report - https://www.delveinsight.com/sample-request/endometriosis-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the key companies in the Endometriosis Pain Therapeutics Market include:
Ferring Pharmaceuticals, ObsEva SA, Myovant Sciences, Hope Medicine Co.Ltd, TiumBio Co.Ltd, Mitsubishi Tanabe Pharma and others.

Request for Sample PDF Report - https://www.delveinsight.com/sample-request/endometriosis-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Content (TOC)
1. Report Introduction
2. Executive Summary
3. Endometriosis Pain Current Treatment Patterns
4. Endometriosis Pain - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Endometriosis Pain Late Stage Products (Phase-III)
7. Endometriosis Pain Mid-Stage Products (Phase-II)
8. Endometriosis Pain Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Endometriosis Pain Discontinued Products
13. Endometriosis Pain Product Profiles
14. Key Companies in the Endometriosis Pain Market
15. Key Products in the Endometriosis Pain Therapeutics Segment
16. Dormant and Discontinued Products
17. Endometriosis Pain Unmet Needs
18. Endometriosis Pain Future Perspectives
19. Endometriosis Pain Analyst Review
20. Appendix
21. Report Methodology
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Trending Reports:
• T-Cell-Prolymphocytic Leukemia Market: https://www.delveinsight.com/report-store/t-cell-prolymphocytic-leukemia-market
• Bone Grafts And Substitutes Market: https://www.delveinsight.com/report-store/bone-grafts-and-substitutes-market
• Hip Replacement Devices Market: https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
• Hepatic Encephalopathy Epidemiology Forecast: https://www.delveinsight.com/report-store/hepatic-encephalopathy-epidemiology-forecast
• Familial Primary Pulmonary Hypertension Market: https://www.delveinsight.com/report-store/familial-primary-pulmonary-hypertension-market
• Global Electrophysiology Devices Market: https://www.delveinsight.com/report-store/electrophysiology-devices-market
• Age Related Vision Dysfunction Market: https://www.delveinsight.com/report-store/age-related-vision-dysfunction-market
• Emesis Market: https://www.delveinsight.com/report-store/emesis-market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endometriosis Pain Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, Growth Prospects, and Key Companies here

News-ID: 2718414 • Views:

More Releases from DelveInsight Business Research

Global Endovascular Aneurysm Repair Devices Market Size to grow at a CAGR of 5.85% to reach USD 4,613.26 million by 2032, Evaluates DelveInsight
Global Endovascular Aneurysm Repair Devices Market Size to grow at a CAGR of 5.8 …
According to DelveInsight's analysis, the increasing prevalence of abdominal and thoracic aortic aneurysms (AAA and TAA) is a major driver of the Endovascular Aneurysm Repair (EVAR) market. With a growing aging population, there is rising demand for minimally invasive treatments like EVAR, which offer benefits such as shorter hospital stays, fewer complications, and faster recovery compared to traditional surgery. Moreover, ongoing technological advancements in EVAR devices such as more flexible
Global Cardiac Mapping System Market Size to grow at a CAGR of 8.37% by 2032, Evaluates DelveInsight
Global Cardiac Mapping System Market Size to grow at a CAGR of 8.37% by 2032, Ev …
According to DelveInsight's analysis, The growing prevalence of cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia, is driving the expansion of the cardiac mapping system market. These systems are crucial for early diagnosis and treatment, providing real-time visualization of the heart's electrical activity to prevent serious complications such as stroke and heart failure. Moreover, the increasing adoption of minimally invasive procedures like catheter ablation, which rely heavily on advanced mapping
Global Male Infertility Market Size to grow at a CAGR of 3.42% to reach USD 5,007.15 million by 2032, Evaluates DelveInsight
Global Male Infertility Market Size to grow at a CAGR of 3.42% to reach USD 5,00 …
According to DelveInsight's analysis, The global male infertility treatments market is being significantly driven by the rising prevalence of male infertility, caused by lifestyle disorders, structural abnormalities, genetic factors, and other underlying conditions. Increased awareness and greater social acceptance have helped reduce stigma, motivating more men to seek medical care. Advancements in diagnostic technologies, including genetic testing and advanced imaging, alongside innovative treatments such as hormonal therapies and minimally invasive
Locally Advanced Pancreatic Cancer Market to Evolve Rapidly Over the Next Decade by 2032, DelveInsight Observes
Locally Advanced Pancreatic Cancer Market to Evolve Rapidly Over the Next Decade …
DelveInsight's "Locally Advanced Pancreatic Cancer Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Locally Advanced Pancreatic Cancer, historical and forecasted epidemiology as well as the Locally Advanced Pancreatic Cancer market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Locally Advanced Pancreatic Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click

All 5 Releases


More Releases for Endometriosis

Endometriosis Pain Market Massive Growth opportunity Ahead
Introduction Endometriosis is a chronic, estrogen-dependent condition in which endometrial-like tissue grows outside the uterus, leading to inflammation, scarring, and adhesions. One of its most debilitating symptoms is pelvic pain, often accompanied by painful periods, infertility, and fatigue. Globally, endometriosis affects an estimated 10% of women of reproductive age, making it a major public health concern. Despite its prevalence, endometriosis pain has historically been underdiagnosed and undertreated. Patients often face diagnostic delays
Elevated Ovarian Cancer Incidence Fuels Growth In The Endometriosis Market: A Ke …
The Endometriosis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Endometriosis Market Size and Its Estimated Growth Rate? In recent years, there has been a swift expansion in the market size of endometriosis. This market is projected to increase from $1.4 billion
Hope for Rapid, Non-Invasive Endometriosis Diagnosis
New diagnostic test for endometriosis, the ENDOSURE test, offers decision support to clinicians with 99.87% accurate results in less than an hour, could transform women's healthcare EDMONTON, AB - In a groundbreaking development for women's health featured on Global News Calgary by journalist Jayme Doll on March 12, 2025, the ENDOSURE test emerges as a beacon of hope for millions suffering from undiagnosed endometriosis in. This non-invasive diagnostic tool promises to
Emerging Endometriosis Market Trend 2025-2034: Innovative Medications Reshaping …
"How Is the Endometriosis Market Projected to Grow, and What Is Its Market Size? The endometriosis market has seen rapid growth in recent years. It is expected to grow from $1.4 billion in 2024 to $1.55 billion in 2025, at a compound annual growth rate (CAGR) of 10.2%. The growth can be attributed to delayed diagnosis, increased awareness, advances in laparoscopic surgery, hormonal therapies, and the support of patient advocacy groups. The
Endometriosis Treatment Market Analysis, Size, Share & Trends | 2031
In recent years, the global Endometriosis Treatment Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Endometriosis Treatment Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five
Endometriosis Market Size, Share, Insight, Treatment 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Endometriosis Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $2.01 billion In 2028 At A